-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The international multi-center randomized controlled study DIRECT-SAFE, which was carried out in cooperation with China, Australia and other countries, was published online in The Lancet (Impact Factor IF=202.
Research Introduction
DIRECT-SAFE is an international, multicenter, prospective, randomized, open-label, endpoint-blinded trial (NCT03494920)
The purpose of this study was to verify whether the clinical outcome of direct thrombectomy within 4.
RESULTS: 295 patients were randomly assigned to either direct thrombectomy (n=148) or bridging therapy (n=147)
Based on the results of the DIRECT-SAFE study, no noninferiority of direct thrombectomy was found compared with bridging therapy
The DIRECT-SAFE study provides evidence to support bridging therapy
.
Although bridging therapy is recommended by default in the guidelines, based on all available clinical research evidence, specific patients with potential increased risk of intravenous thrombolysis, including late time windows or large infarct volumes, and direct travel can quickly provide For patients in hospitals where emergency endovascular thrombectomy is performed, direct mechanical thrombectomy can be considered
.
.
Author: Professor Huo Xiaochuan of Beijing Tiantan Hospital Wen Yuan: "Neural Intervention Online"